Prospective Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Nov 7, 2016; 22(41): 9214-9221
Published online Nov 7, 2016. doi: 10.3748/wjg.v22.i41.9214
Table 2 Molecular detection of Helicobacter pylori infection and resistance-mediating mutations using biopsies from CLO-positive endoscopy patients and stool samples of Urea Breath Test-positive patients
Biopsy SpecimensStool specimensP value95%CI
Total analysedn = 55n = 66
H. pylori DNA positive98.2% (n = 54/55)80.3 % (n = 53/66)< 0.0056.10-29.66
Clarithromycin resistant51.9% (n = 28/54)96.2 % (n = 51/53)< 0.00127.70-58.71
Fluoroquinolone resistant9.3 % (n = 5/54)113 % (n = 6/46)10.55-9.99-18.28